The localization of topoisomerase II cleavage sites on DNA in the presence of antitumor drugs
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 60 (2), 381-387
- https://doi.org/10.1016/0163-7258(93)90018-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Sequence-specific transactivators counteract topoisomerase II-mediated inhibition ofin vitrotranscription by RNA polymerases I and IINucleic Acids Research, 1993
- Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylationBiochemistry, 1993
- Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase IIBiochemistry, 1993
- Chromosome assembly in vitro: Topoisomerase II is required for condensationCell, 1991
- Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicityBiochemistry, 1990
- Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicinNucleic Acids Research, 1990
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- Inhibition of type II topoisomerase by fostriecinBiochemical Pharmacology, 1988
- Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutantsCell, 1988
- The generality of self-splicing RNA: Relationship to nuclear mRNA splicingCell, 1986